or Try an Advanced Search...

    Technical Analysis for ACRS - Aclaris Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 3.80 -12.04% -0.52
    ACRS closed down 12.04 percent on Friday, November 22, 2024, on 1.14 times normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Very Strong Up Up Up
    Historical ACRS trend table...
    Date Alert Name Type % Chg
    Parabolic Rise Strength 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Wide Bands Range Expansion 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Calm After Storm Range Contraction -12.04%
    Parabolic Rise Strength -12.04%
    Upper Bollinger Band Walk Strength -12.04%
    Wide Bands Range Expansion -12.04%
    Above Upper BB Strength -12.04%
    Gapped Up Strength -12.04%
    Older End-of-Day Signals for ACRS ...

       Recent Intraday Alerts

    Alert Time
    Down 10% 1 day ago
    Fell Below Previous Day's Low 1 day ago
    60 Minute Opening Range Breakdown 1 day ago
    Down 5% 1 day ago
    Up 2% 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    ACRS Chart by TradingView
    Basic chart:

    Profile

    Aclaris Therapeutics, Inc., a clinical-stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical drugs to address various unmet needs in dermatology. Its lead drug candidate is A-101, a hydrogen peroxide topical solution that has completed three Phase II clinical trials for the treatment of seborrheic keratosis (SK), a common non-malignant skin tumor. The company is also developing A-101 as a prescription treatment for common warts; and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts. Aclaris Therapeutics, Inc. was founded in 2012 and is headquartered in Malvern, Pennsylvania.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Pharmaceutical Chemical Substances Hydrogen Dermatology Hydrogen Peroxide Stage Specialty Pharmaceutical Topical Medication Common Warts Keratosis

    Is ACRS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 22 Aclaris Therapeutics And 2 Other US Penny Stocks To Watch
    Nov 20 Aclaris upgraded to overweight by Cantor on in-licensing deal
    Nov 20 Aclaris Therapeutics upgraded to Buy from Hold at Jefferies
    Nov 20 Aclaris Therapeutics upgraded to Buy from Neutral at BTIG
    Nov 19 Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments
    Nov 19 Aclaris stock soars for second day on licensing deal, analyst upgrades
    Nov 19 Aclaris Therapeutics secures global rights to Biosion’s antibodies
    Nov 19 ACRS Stock Up on Licensing Deal With Biosion for Two Immunology Drugs
    Nov 18 Aclaris stock rallies 53% amid licensing deal, Piper upgrade
    Nov 18 Aclaris signs license deal for biologics assets
    See more ACRS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.17
    52 Week Low 0.8
    Average Volume 2,613,649
    200-Day Moving Average 1.35
    50-Day Moving Average 1.77
    20-Day Moving Average 2.62
    10-Day Moving Average 3.17
    Average True Range 0.48
    RSI (14) 65.64
    ADX 52.88
    +DI 43.75
    -DI 11.49
    Chandelier Exit (Long, 3 ATRs) 3.74
    Chandelier Exit (Short, 3 ATRs) 2.69
    Upper Bollinger Bands 4.34
    Lower Bollinger Band 0.90
    Percent B (%b) 0.84
    BandWidth 131.09
    MACD Line 0.63
    MACD Signal Line 0.47
    MACD Histogram 0.1658
    Fundamentals Value
    Market Cap 269.18 Million
    Num Shares 70.8 Million
    EPS -1.66
    Price-to-Earnings (P/E) Ratio -2.29
    Price-to-Sales 4.00
    Price-to-Book 0.56
    PEG Ratio -0.13
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.76
    Resistance 3 (R3) 4.87 4.65 4.60
    Resistance 2 (R2) 4.65 4.41 4.60 4.55
    Resistance 1 (R1) 4.23 4.26 4.12 4.12 4.49
    Pivot Point 4.01 4.01 3.96 3.96 4.01
    Support 1 (S1) 3.59 3.77 3.48 3.48 3.11
    Support 2 (S2) 3.37 3.62 3.32 3.05
    Support 3 (S3) 2.95 3.37 3.00
    Support 4 (S4) 2.84